Esperion Therapeutics Announces the Appointment of Scott Braunstein, M.D. to Board of Directors by longitudeadmin | Jun 15, 2015 | Portfolio News
Collegium Announces Issuance of U.S. Patent Covering DETERx® – an Abuse-Deterrent, Extended-Release Technology Platform by longitudeadmin | Jun 8, 2015 | Portfolio News
Aimmune Therapeutics Announces Positive Phase 2 Study Results of AR101 for the Treatment of Peanut Allergy by longitudeadmin | Jun 7, 2015 | Portfolio News
Collegium Expands Commercial Organization With Key Appointments by longitudeadmin | Jun 1, 2015 | Portfolio News